Skip to content

Clinical trials

Completed Phase 2 Bone Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases Phase: Phase 2 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20092
20102
20113
20121
20132
20142
20151
20182
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.4
Northwestern University4
BioMarin Pharmaceutical2
Amgen1
AstraZeneca1
Erasme University Hospital1
Merck Sharp & Dohme LLC1
National Heart, Lung, and Blood Institute (NHLBI)1
National Institute of Neurological Disorders and Stroke (NINDS)1
QED Therapeutics, a BridgeBio company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases22
Osteoporosis9
Bone Diseases, Metabolic8
Musculoskeletal Diseases8
Hypophosphatasia4
Osteomalacia4
Rickets4
Spinal Cord Diseases4
Spinal Cord Injuries4
Achondroplasia3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.